- •We reviewed 145 cases to compare the efficacy of percutaneous radiofrequency and microwave ablation for treating HCC.
- •There was no overall difference efficacy between the microwave and radiofrequency ablation for the treatment of HC
- •Microwave ablation procedures combined with same-day biopsy were associated with increased risk of primary failure.
- •HCC that were located adjacent to other organs and were treated with MW ablation were at higher risk of local progression.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Management of hepatocellular carcinoma: an update.Hepatology. 2011; 53: 1020-1022https://doi.org/10.1002/hep.24199
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.J Hepatol. 2012; 57: 794-802https://doi.org/10.1016/j.jhep.2012.05.007
- A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.Ann Surg. 2010; 252: 903-912https://doi.org/10.1097/SLA.0b013e3181efc656
- Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model.Radiology. 2013; 267: 129-136https://doi.org/10.1148/radiol.12120486
- Treatment of intermediate-stage hepatocellular carcinoma.Nat Rev Clin Oncol. 2014; 11: 525-535https://doi.org/10.1038/nrclinonc.2014.122
- Percutaneous microwave ablation of hepatocellular carcinoma with a gas-cooled system: initial clinical results with 107 tumors.J Vasc Int Radiol. 2015; 26: 62-68https://doi.org/10.1016/j.jvir.2014.09.012
- Radiofrequency versus microwave ablation in a hepatic porcine model.Radiology. 2005; 236: 132-139https://doi.org/10.1148/radiol.2361031249
- Microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a comparison of efficacy at a single center.J Vasc Int Radiol. 2016; 27: 631-638https://doi.org/10.1016/j.jvir.2016.01.136
- Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation.Abdom Imaging. 2015; 40: 1829-1837https://doi.org/10.1007/s00261-015-0355-6
- Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update.J Vasc Interv Radiol. 2014; 25: 1691-1705https://doi.org/10.1016/j.jvir.2014.08.027
- Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome.Ann Surg Oncol. 2014; 21: 1287-1295https://doi.org/10.1245/s10434-013-3413-8
- Staging systems in hepatocellular carcinoma.HPB (Oxford). 2005; 7: 35-41https://doi.org/10.1080/13651820410024058
- Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control.J Vasc Int Radiol. 2018; 29: 268-275https://doi.org/10.1016/j.jvir.2017.08.021
Kariyama K, Nouso K, Wakuta A, Kishida M, Nishimura M, Wada N et al. Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma in the caudate lobe. Am J Roentgenol. 2011;197(4):W571-W5. doi:https://doi.org/10.2214/AJR.11.6893.
- Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients.Eur Radiol. 2009; 19: 2630-2640https://doi.org/10.1007/s00330-009-1463-x
- Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.Br J Surg. 2006; 93: 1277-1282https://doi.org/10.1002/bjs.5374
- Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.Cancer. 2003; 97: 1253-1262https://doi.org/10.1002/cncr.11168
- Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.J Gastroenterol. 2003; 38: 977-981https://doi.org/10.1007/s00535-003-1181-0
- Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation.Radiology. 2005; 235: 299-307https://doi.org/10.1148/radiol.2351031944
- Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of practice committee.J Vasc Int Radiol. 2017; 28: 1432-1437https://doi.org/10.1016/j.jvir.2017.06.019
- Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.Semin Liver Dis. 2010; 30: 52-60https://doi.org/10.1055/s-0030-1247132
- Propensity scores: uses and limitations.PM&R. 2012; 4: 693-697https://doi.org/10.1016/j.pmrj.2012.07.002
- Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies.Eur Radiol. 2012; 22: 1983-1990https://doi.org/10.1007/s00330-012-2442-1
- Microwave ablation compared to radiofrequency ablation for hepatic lesions: a meta-analysis.J Vasc Int Radiol. 2015; 26: 1139-1146https://doi.org/10.1016/j.jvir.2015.04.004
- Radiofrequency ablation and microwave ablation in liver tumors: an update.Oncologist. 2019; 24: e990-e1005https://doi.org/10.1634/theoncologist.2018-0337
- Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis.Int J Hyperthermia. 2016; 32: 339-344https://doi.org/10.3109/02656736.2015.1127434
- Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.Int J Hyperthermia. 2019; 36: 263-271https://doi.org/10.1080/02656736.2018.1562571
- Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a multiple centers retrospective cohort study with propensity score matching.PloS one. 2020; 15e0227242-ehttps://doi.org/10.1371/journal.pone.0227242
- Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome?: seeding risk for percutaneous approach of HCC.Cancer Treat Rev. 2007; 33: 437-447https://doi.org/10.1016/j.ctrv.2007.04.001
- Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis.Gut. 2008; 57: 1592-1596https://doi.org/10.1136/gut.2008.149062
- Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.Hepatology. 2001; 33: 1124-1129https://doi.org/10.1053/jhep.2001.24233
- Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.Br J Surg. 2005; 92: 856-858https://doi.org/10.1002/bjs.4986
Bruix J, Han K-H, Gores G, Llovet JM, Mazzaferro V. Liver cancer: approaching a personalized care. J Hepatol. 2015;62(1):S144-S56. doi:https://doi.org/10.1016/j.jhep.2015.02.007.
- Personalized therapy for hepatocellular carcinoma: where are we now?.Cancer Treat Rev. 2016; 45: 77-86https://doi.org/10.1016/j.ctrv.2016.02.008
- Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.J Hepatol. 2013; 58: 89-97https://doi.org/10.1016/j.jhep.2012.09.020
- Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma.PLoS ONE. 2013; 8e76119https://doi.org/10.1371/journal.pone.0076119
☆All authors meet criteria for authorship.